Olema Pharmaceuticals is developing palazestrant, an oral SERD in phase 3 trials for ER+/HER2- metastatic breast cancer, with promising early data in combination with ribociclib. Despite positive ...
Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.
A tough day for those writing off UConn women. Maybe the Huskies rediscovered the championship pedigree with a blowout win at South Carolina.
Tour the campus. Sit in on a class. Talk with professors, coaches, staff, and current students. Located in the heart of Middletown, Connecticut, near tons of great restaurants, hiking trails, and ...
The damaging wind threat will end this evening but a cold breeze remains. Watching a storm Thursday but it likely misses us.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results